1,2,5,8-tetrahydroxy anthraquinone has been researched along with cx 4945 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balanda, AO; Bdzhola, VG; Briukhovetska, NV; Golub, AG; Gryshchenko, AA; Kotey, IM; Kukharenko, OP; Ostrynska, OV; Yarmoluk, SM | 1 |
| Chen, T; Chen, Y; Feng, F; Guo, Q; Lin, H; Liu, W; Liu, Z; Qiao, Y; Qu, W; Sun, H; Yang, H | 1 |
| Gorjup, E; Götz, C; Kartarius, S; Montenarh, M; Schwind, L; Wilhelm, N | 1 |
| Hong, J; Jie, X; Li, K; Li, Q; Li, Z; Meng, R; Wu, B; Wu, G; Zhang, S; Zhou, X; Zong, Y | 1 |
1 review(s) available for 1,2,5,8-tetrahydroxy anthraquinone and cx 4945
| Article | Year |
|---|---|
Small molecule modulators targeting protein kinase CK1 and CK2.
Topics: Animals; Casein Kinase I; Casein Kinase II; Drug Discovery; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Small Molecule Libraries | 2019 |
3 other study(ies) available for 1,2,5,8-tetrahydroxy anthraquinone and cx 4945
| Article | Year |
|---|---|
Design and synthesis of novel protein kinase CK2 inhibitors on the base of 4-aminothieno[2,3-d]pyrimidines.
Topics: Casein Kinase II; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship | 2016 |
Protein kinase CK2 is necessary for the adipogenic differentiation of human mesenchymal stem cells.
Topics: Active Transport, Cell Nucleus; Adipogenesis; Animals; Anthraquinones; Casein Kinase II; Cell Differentiation; Cell Nucleus; Cell Proliferation; Female; Humans; Male; Mesenchymal Stem Cells; Naphthyridines; Phenazines; PPAR gamma | 2015 |
Involvement of endothelial CK2 in the radiation induced perivascular resistant niche (PVRN) and the induction of radioresistance for non-small cell lung cancer (NSCLC) cells.
Topics: Anthraquinones; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Casein Kinase II; Cytokines; Endothelial Cells; Endothelium, Vascular; Humans; Lung Neoplasms; Naphthyridines; Phenazines; Protein Kinase Inhibitors | 2019 |